Forward Citations = 2

Loading Chart...

13 inventors (with patents filed for the assignee):

Dennis M Brown (6 out of 30 patents)

Jeffrey A Bacha (6 out of 8 patents)

Anne Steinø (3 out of 4 patents)

4. Sandra Dunn (2 out of 6 patents)

5. Kent C Shih (1 out of 1 patent)

6. Anne Steino (1 out of 1 patent)

7. Richard Schwartz (1 out of 1 patent)

8. Sarath Kanekal (1 out of 1 patent)

9. Howard A Burris, Iii (1 out of 1 patent)

10. Shaun Fouse (1 out of 1 patent)

11. Qiang Xu (1 out of 1 patent)

12. Xiaoyun Liu (1 out of 2 patents)

13. William J Garner (1 out of 17 patents)

8 patents: Sort by Forward Citations

1. 11717505 - Dianhydrogalactitol for the treatment of diffuse intrinsic pontine gliomas (2023-08-08),

2. 11541027 - Use of dianhydrogalactitol and analogs or derivatives thereof in combination with platinum-containing antineoplastic agents to treat non-small-cell carcinoma of the lung and brain metastases (2023-01-03),

3. 11446274 - Use of dianhydrogalactitol or derivatives or analogs thereof for treatment of pediatric central nervous system malignancies (2022-09-20),

4. 11234955 - Use of substituted hexitols including dianhydrogalactitol and analogs to treat neoplastic disease and cancer stem cells including glioblastoma multiforme and medulloblastoma (2022-02-01),

5. 11026914 - Use of dianhydrogalactitol and analogs and derivatives thereof to treat recurrent malignant glioma or progressive secondary brain tumor (2021-06-08),

6. 10591445 - Methods for analysis and resolution of preparations of dianhydrogalactitol and derivatives or analogs thereof (2020-03-17),

7. 10201521 - Use of substituted hexitols including dianhydrogalactitol and analogs to treat neoplastic disease and cancer stem and cancer stem cells including glioblastoma multiforme and medulloblastoma (2019-02-12),

8. 10145824 - Analytical methods for analyzing and determining impurities in dianhydrogalactitol (2018-12-04),

Company Overview

Del Mar Pharmaceuticals (bc) Ltd. is a biopharmaceutical company dedicated to developing and commercializing novel cancer therapies. Our lead product candidate, VAL-083, is a potential treatment for a range of cancers, including glioblastoma, ovarian, and lung cancer. We are committed to advancing innovative therapies that address unmet medical needs and improve patient outcomes.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 13 2026

8 Patents

#121 in Vancouver

#1,878 in Canada

Vancouver, Canada

Del Mar Pharmaceuticals (Bc) Ltd.

Forward Citations = 2

13 inventors:

Dennis M Brown (6 out of 30 patents)

Jeffrey A Bacha (6 out of 8 patents)

Anne Steinø (3 out of 4 patents)

4. Sandra Dunn (2 out of 6 patents)

5. Kent C Shih (1 out of 1 patent)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Del Mar Pharmaceuticals (Bc) Ltd.. Retrieved from https://idiyas.com/company/del-mar-pharmaceuticals-bc

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]